Bridgeway Capital Management’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-50,000
Closed -$7.85K 1444
2023
Q3
$7.85K Sell
50,000
-50,000
-50% -$13.3K ﹤0.01% 1357
2023
Q2
$25.8K Hold
100,000
﹤0.01% 1356
2023
Q1
$32K Hold
100,000
﹤0.01% 1343
2022
Q4
$42K Hold
100,000
﹤0.01% 1312
2022
Q3
$97K Buy
+100,000
New +$177K ﹤0.01% 1274

Other funds holding AMTI

Bridgeway Capital Management's AMTI Position: Q4 2023 in Review

Bridgeway Capital Management sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q4 2023, closing a stake of 50,000 shares — an estimated $7.85K sold.

Bridgeway Capital Management first reported a position in AMTI in Q3 2022 and held it in 5 quarters. The position peaked at $97K in Q3 2022. 2 funds tracked by Wall St. Rank hold AMTI as of Q4 2023.

  • Bridgeway Capital Management reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 50,000 Applied Molecular Transport Inc. Common Stock shares in Q4 2023, an estimated $7.85K.
  • Bridgeway Capital Management first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Bridgeway Capital Management's Applied Molecular Transport Inc. Common Stock position peaked at $97K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q4 2023.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.